New products
VDyne treats first patient in TRIVITA trial of TriNova system
VDyne has enrolled and treated the first patient in the TRIVITA US IDE pivotal study of its TriNova transcatheter tricuspid valve replacement system. The trial is designed to evaluate safety and efficacy of the device in patients with symptomatic tricuspid regurgitation.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network